Skip to Content

2 Results Found

  • Review
  • Open Access
16 Citations
9,031 Views
15 Pages

VALTOCO® (Diazepam Nasal Spray) for the Acute Treatment of Intermittent Stereotypic Episodes of Frequent Seizure Activity

  • Elyse M. Cornett,
  • Sam N. Amarasinghe,
  • Alexis Angelette,
  • Tunde Abubakar and ,
  • Adam M. Kaye,
  • Alan David Kaye,
  • Elisa E. Neuchat,
  • Ivan Urits and
  • Omar Viswanath
  • + 4 authors+ 0 author

18 February 2021

Valtoco® is a new FDA-approved nasal spray version of diazepam indicated for the treatment of acute, intermittent, and stereotypic episodes of frequent seizure activity in epilepsy patients six years of age and older. Although IV and rectal diazepam...

  • Review
  • Open Access
40 Citations
15,442 Views
17 Pages

Benzodiazepines such as diazepam, lorazepam and midazolam remained the mainstay of treatment for acute repetitive seizures (ARS). The immediate care for ARS should often begin at home by a caregiver. This prevents the progression of ARS to prolonged...

(This article belongs to the Special Issue Nose to Brain Delivery (Volume II))